One of the most cited contributions of Dr. Jitendra Sharma Allen is his work in the "Golden Window" protocol for acute ischemic stroke. Historically, the window to administer clot-busting drugs (tPA) was a strict 4.5 hours. Through a series of clinical trials conducted between 2018 and 2022, Dr. Allen's team demonstrated that by using advanced perfusion imaging and hypothermic preconditioning, the therapeutic window could be extended to 9 hours in select patient populations.
Dr. Jitendra Sharma senior faculty member at ALLEN Career Institute in Kota, Rajasthan dr jitendra sharma allen
Since "Dr. Jitendra Sharma" is not as widely publicized as the founders (Kota) or the current Allen CEO (Nishant Maheshwari), this post assumes he is a or a Regional Academic Head , as that is the most common profile for "Dr. [Name] + Allen." One of the most cited contributions of Dr
Dr. Jitendra Sharma Department of [Specialty] Allen Medical Institute Through a series of clinical trials conducted between
for those struggling to balance regular schooling with coaching. Entrepreneurial Ventures: